Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $122.8 million.

  • Privia Health's Shares Outstanding (Weighted Average) rose 259.93% to $122.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.8 million, marking a year-over-year increase of 259.93%. This contributed to the annual value of $119.4 million for FY2024, which is 228.85% up from last year.
  • Per Privia Health's latest filing, its Shares Outstanding (Weighted Average) stood at $122.8 million for Q3 2025, which was up 259.93% from $122.1 million recorded in Q2 2025.
  • In the past 5 years, Privia Health's Shares Outstanding (Weighted Average) ranged from a high of $122.8 million in Q3 2025 and a low of $96.0 million during Q1 2021
  • Over the past 5 years, Privia Health's median Shares Outstanding (Weighted Average) value was $116.2 million (recorded in 2023), while the average stood at $113.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first grew by 5.66% in 2021, then skyrocketed by 1257.82% in 2022.
  • Quarter analysis of 5 years shows Privia Health's Shares Outstanding (Weighted Average) stood at $103.0 million in 2021, then increased by 7.52% to $110.7 million in 2022, then grew by 5.45% to $116.7 million in 2023, then rose by 2.29% to $119.4 million in 2024, then increased by 2.82% to $122.8 million in 2025.
  • Its last three reported values are $122.8 million in Q3 2025, $122.1 million for Q2 2025, and $120.6 million during Q1 2025.